Page last updated: 2024-12-11

9-oxo-15-hydroxy-delta 7,10,13-prostatrienoic acid methyl ester

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6438550
CHEMBL ID104747
MeSH IDM0139458

Synonyms (7)

Synonym
CHEMBL104747
methyl (7e)-7-[(2s)-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-ylidene]heptanoate
delta(7)-pga(1) methyl ester
prosta-7,10,13-trien-1-oic acid, 15-hydroxy-9-oxo-, methyl ester, (7e,13e,15s)-
delta 7-pga1
92711-55-2
9-oxo-15-hydroxy-delta 7,10,13-prostatrienoic acid methyl ester
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID9800Growth inhibition time for A172 Human Glioma cell growth at concentration 5 uM1998Journal of medicinal chemistry, Jul-30, Volume: 41, Issue:16
Rational design of antitumor prostaglandins with high biological stability.
AID1469815Glutathione reactivity of the compound in CD3OD/deuterio phosphate buffer assessed as equilibrium constant for adduct formation at pH 7.4 by UV spectroscopic analysis2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
AID1469811Methanethiol reactivity of the compound in CD3OD/deuterio phosphate buffer assessed as equilibrium constant for adduct formation at pH 7.4 by UV spectroscopic analysis2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
AID1469812Butanethiol reactivity of the compound in CD3OD/deuterio phosphate buffer assessed as equilibrium constant for adduct formation at pH 7.4 by UV spectroscopic analysis2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
AID309205Inhibition of manganese ion-induced apoptosis in PC12 cells assessesed as suppression of DNA fragmentation upto 20 uM2007Bioorganic & medicinal chemistry letters, Oct-01, Volume: 17, Issue:19
Synthesis of neuroprotective cyclopentenone prostaglandin analogs: suppression of manganese-induced apoptosis of PC12 cells.
AID1469813Beta-mercaptoethanol reactivity of the compound in CD3OD/deuterio phosphate buffer assessed as equilibrium constant for adduct formation at pH 7.4 by UV spectroscopic analysis2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
AID309206Toxicity in PC12 cells assessed by measuring DNA fragmentation at 10 uM2007Bioorganic & medicinal chemistry letters, Oct-01, Volume: 17, Issue:19
Synthesis of neuroprotective cyclopentenone prostaglandin analogs: suppression of manganese-induced apoptosis of PC12 cells.
AID1469814Cysteine reactivity of the compound in CD3OD/deuterio phosphate buffer assessed as equilibrium constant for adduct formation at pH 7.4 by UV spectroscopic analysis2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (35.71)18.7374
1990's6 (42.86)18.2507
2000's2 (14.29)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.57 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]